admin In this digital era, where health information is available at the fingertips, tech-savvy people are looking at expert advice and proactive care from the health industry. And moving from treatment to preventive scenarios, life sciences companies are trying to keep the beat with people. With changing circumstances big data is playing a vital role in the health industry, and understanding the big picture of its importance in medicine and recognizing the real-world applications of data analytics as they’re being used today is crucial.
Pointing analogous in today’s data driven medicine Elizabeth Parrish the Founder & CEO of BioViva asserts – “We are focused on saving as many lives as possible by making tomorrow’s therapies available today. This is about Life and Death. Risk aversion and delaying the approval of therapies that have been successful in research kills.” Also, she is actively dedicated to safeguarding healthy longevity for all.
Elizabeth Parrish is a humanitarian, entrepreneur, innovator, author, podcaster, and a leading voice for genetic cures. As a proponent of progress and education for the advancement of regenerative medicine modalities, she serves as a motivational speaker to the public for the life sciences. She is actively involved in international educational media outreach.
[mks_col] [mks_one_half]The ability to partake in a treatment is a human’s right, to be able to do it as safely as possible is a medical doctor’s job, and proving whether the therapy works is BioViva’s work[/mks_one_half] [mks_one_half]
Under the leadership of Elizabeth, BioViva is collecting as much data, both from people all over the world who have had their genomes and epigenomes analysed with company’s products as well as patients participating in the cutting edge trials offered by its partner company, Integrated Health Systems. These data sets will be anonymized and made available to labs and drug companies worldwide to speed up research and development in the area of longevity medicine.
[/mks_one_half] [/mks_col]Groundbreaking Gene Therapies
Unlike many biotech companies, BioViva is motivated as much by compassion, a concern for others, and the necessity to create a kinder world with less suffering, as by financial gain. And it is the first to partner with a company that offers groundbreaking gene therapies designed to address the issues of aging to consensual patients in need. These therapies had already proven successful in animal models.
‘Passion is The Key for Success’
Passionate enough to cope with little funding and considerable resistance from the medical and scientific community, Elizabeth believes that passion is her strength. It has given her the energy to continue even when criticism was unfair, rooted in ignorance and closed mindsets.
This passion also drove her for trial therapy in Bogota in 2015 on herself, although it had already been successful in animal models, she wanted to be sure it was safe for humans.
BioViva’s Core Aspects: Synergies, Accessibility, and Efficacy
According to Elizabeth, the three most important concepts for BioViva are, first collaboration with its partner company Integrated Health Systems to speed up the process by which gene therapies that have proven successful in animals are made available to patients who have no other option. Second, to make these therapies affordable to all. And third, to use gene therapy to address cellular damage due to time, aka aging.
‘Team Work is Support Pillar’
BioViva’s team is collaborating to develop a bioinformatics platform that will make medical data from clinical gene therapy trials accessible to R&D. It includes Computer Scientists, Writers, and Market Analysts.
Customer Base: Innovation, Interaction, and Integration
For BioViva ideal client understands that its the time to address the body at a molecular level and kits that analyse part of his genome or epigenome not only helping him to take better care of his own health but also helps the R&D of new cutting edge drugs. And for IHS the ideal client is not just receiving a therapy that will benefit him, he is also contributing medical data to our database that will help medicine move forward. BioViva believes in clients as partners, collaborators, and members of their extended team and both are helping each other.
Feedback and Criticism: Scope of Improvement
Elizabeth ensures that feedback and criticism are crucial and take them very seriously. It helps improve the company’s service and understand clients’ needs and demands.
Comprehensive Future Plans
While explaining BioViva’s future goals, Elizabeth said, “At the moment we hope to expand our range of medical analysis kits. We hope that in the very near future we will offer kits for all aspects of physical health: genomic, epigenomic, and microbiomic. Kits to measure your biological age and reveal your susceptibility to certain health issues. This will yield data that we will store safely and anonymously in a data vault so that our clients can see how their own health is evolving over time and act accordingly.” She added, “We hope to inspire the FDA to become less risk averse and allow cutting-edge therapies in the USA. We don’t understand why some very sick people must die because the therapy they need is only available to animals.”
Magazine 
